1Department of Obstetrics and Gynecology, Carver College of Medicine,University of Iowa, 2Cancer Biology Graduate Program, Carver College of Medicine,University of Iowa, 3The Institute of Cancer Research: and the Royal Marsden NHS Foundation Trust, 4Department of Radiation Oncology, Carver College of Medicine,University of Iowa, 5Division of Molecular Medicine, Departments of Internal Medicine and Obstetrics and Gynecology,University of New Mexico Comprehensive Cancer Center, University of New Mexico Health Sciences Center, 6Agilent Technologies, 7Holden Comprehensive Cancer Center,University of Iowa
Autor
Institution
1Department of Obstetrics and Gynecology, Carver College of Medicine,University of Iowa, 2Cancer Biology Graduate Program, Carver College of Medicine,University of Iowa, 3The Institute of Cancer Research: and the Royal Marsden NHS Foundation Trust, 4Department of Radiation Oncology, Carver College of Medicine,University of Iowa, 5Division of Molecular Medicine, Departments of Internal Medicine and Obstetrics and Gynecology,University of New Mexico Comprehensive Cancer Center, University of New Mexico Health Sciences Center, 6Agilent Technologies, 7Holden Comprehensive Cancer Center,University of Iowa
AUTHORS
1Department of Obstetrics and Gynecology, Carver College of Medicine,University of Iowa, 2Cancer Biology Graduate Program, Carver College of Medicine,University of Iowa, 3The Institute of Cancer Research: and the Royal Marsden NHS Foundation Trust, 4Department of Radiation Oncology, Carver College of Medicine,University of Iowa, 5Division of Molecular Medicine, Departments of Internal Medicine and Obstetrics and Gynecology,University of New Mexico Comprehensive Cancer Center, University of New Mexico Health Sciences Center, 6Agilent Technologies, 7Holden Comprehensive Cancer Center,University of Iowa
Autor
Institution
1Department of Obstetrics and Gynecology, Carver College of Medicine,University of Iowa, 2Cancer Biology Graduate Program, Carver College of Medicine,University of Iowa, 3The Institute of Cancer Research: and the Royal Marsden NHS Foundation Trust, 4Department of Radiation Oncology, Carver College of Medicine,University of Iowa, 5Division of Molecular Medicine, Departments of Internal Medicine and Obstetrics and Gynecology,University of New Mexico Comprehensive Cancer Center, University of New Mexico Health Sciences Center, 6Agilent Technologies, 7Holden Comprehensive Cancer Center,University of Iowa
AUTHORS
1Department of Obstetrics and Gynecology, Carver College of Medicine,University of Iowa, 2Cancer Biology Graduate Program, Carver College of Medicine,University of Iowa, 3The Institute of Cancer Research: and the Royal Marsden NHS Foundation Trust, 4Department of Radiation Oncology, Carver College of Medicine,University of Iowa, 5Division of Molecular Medicine, Departments of Internal Medicine and Obstetrics and Gynecology,University of New Mexico Comprehensive Cancer Center, University of New Mexico Health Sciences Center, 6Agilent Technologies, 7Holden Comprehensive Cancer Center,University of Iowa
Autor
Institution
1Department of Obstetrics and Gynecology, Carver College of Medicine,University of Iowa, 2Cancer Biology Graduate Program, Carver College of Medicine,University of Iowa, 3The Institute of Cancer Research: and the Royal Marsden NHS Foundation Trust, 4Department of Radiation Oncology, Carver College of Medicine,University of Iowa, 5Division of Molecular Medicine, Departments of Internal Medicine and Obstetrics and Gynecology,University of New Mexico Comprehensive Cancer Center, University of New Mexico Health Sciences Center, 6Agilent Technologies, 7Holden Comprehensive Cancer Center,University of Iowa
AUTHORS
1Renal Section, Department of Medicine, Chobanian and Avedisian School of Medicine,Boston University, 2Vascular Biology Section, Department of Medicine, Chobanian and Avedisian School of Medicine,Boston University, 3Division of Interventional Radiology, Department of Radiology, Chobanian and Avedisian School of Medicine,Boston University, 4Department of Medicine, Whitaker Cardiovascular Institute, Chobanian and Avedisian School of Medicine,Boston University, 5Department of Biochemistry and Cell Biology, Chobanian and Avedisian School of Medicine,Boston University, 6Veterans Affairs Boston Healthcare System, 7Institute of Medical Engineering and Sciences,Massachusetts Institute of Technology, 8Center of Cross-Organ Vascular Pathology, Department of Medicine, Chobanian and Avedisian School of Medicine,Boston University
Autor
Institution
1Renal Section, Department of Medicine, Chobanian and Avedisian School of Medicine,Boston University, 2Vascular Biology Section, Department of Medicine, Chobanian and Avedisian School of Medicine,Boston University, 3Division of Interventional Radiology, Department of Radiology, Chobanian and Avedisian School of Medicine,Boston University, 4Department of Medicine, Whitaker Cardiovascular Institute, Chobanian and Avedisian School of Medicine,Boston University, 5Department of Biochemistry and Cell Biology, Chobanian and Avedisian School of Medicine,Boston University, 6Veterans Affairs Boston Healthcare System, 7Institute of Medical Engineering and Sciences,Massachusetts Institute of Technology, 8Center of Cross-Organ Vascular Pathology, Department of Medicine, Chobanian and Avedisian School of Medicine,Boston University
AUTHORS
1Renal Section, Department of Medicine, Chobanian and Avedisian School of Medicine,Boston University, 2Vascular Biology Section, Department of Medicine, Chobanian and Avedisian School of Medicine,Boston University, 3Division of Interventional Radiology, Department of Radiology, Chobanian and Avedisian School of Medicine,Boston University, 4Department of Medicine, Whitaker Cardiovascular Institute, Chobanian and Avedisian School of Medicine,Boston University, 5Department of Biochemistry and Cell Biology, Chobanian and Avedisian School of Medicine,Boston University, 6Veterans Affairs Boston Healthcare System, 7Institute of Medical Engineering and Sciences,Massachusetts Institute of Technology, 8Center of Cross-Organ Vascular Pathology, Department of Medicine, Chobanian and Avedisian School of Medicine,Boston University
Autor
Institution
1Renal Section, Department of Medicine, Chobanian and Avedisian School of Medicine,Boston University, 2Vascular Biology Section, Department of Medicine, Chobanian and Avedisian School of Medicine,Boston University, 3Division of Interventional Radiology, Department of Radiology, Chobanian and Avedisian School of Medicine,Boston University, 4Department of Medicine, Whitaker Cardiovascular Institute, Chobanian and Avedisian School of Medicine,Boston University, 5Department of Biochemistry and Cell Biology, Chobanian and Avedisian School of Medicine,Boston University, 6Veterans Affairs Boston Healthcare System, 7Institute of Medical Engineering and Sciences,Massachusetts Institute of Technology, 8Center of Cross-Organ Vascular Pathology, Department of Medicine, Chobanian and Avedisian School of Medicine,Boston University
AUTHORS
1Department of Pathology,Hospital Universitario y Politécnico La Fe, 2Department of Urology,Hospital Universitario y Politécnico La Fe, 3Biobanco La Fe,Instituto de Investigación Sanitaria La Fe, 4Department of Medicine,Jaume I University of Castellon, 5Department of Surgery,University of Valencia, 6Department of Pathology,University of Valencia
Autor
Institution
1Department of Pathology,Hospital Universitario y Politécnico La Fe, 2Department of Urology,Hospital Universitario y Politécnico La Fe, 3Biobanco La Fe,Instituto de Investigación Sanitaria La Fe, 4Department of Medicine,Jaume I University of Castellon, 5Department of Surgery,University of Valencia, 6Department of Pathology,University of Valencia
AUTHORS
1Department of Pathology,Hospital Universitario y Politécnico La Fe, 2Department of Urology,Hospital Universitario y Politécnico La Fe, 3Biobanco La Fe,Instituto de Investigación Sanitaria La Fe, 4Department of Medicine,Jaume I University of Castellon, 5Department of Surgery,University of Valencia, 6Department of Pathology,University of Valencia
Autor
Institution
1Department of Pathology,Hospital Universitario y Politécnico La Fe, 2Department of Urology,Hospital Universitario y Politécnico La Fe, 3Biobanco La Fe,Instituto de Investigación Sanitaria La Fe, 4Department of Medicine,Jaume I University of Castellon, 5Department of Surgery,University of Valencia, 6Department of Pathology,University of Valencia
AUTHORS
1Wilmot Cancer Institute,University of Rochester Medical Center, 2Department of Biomedical Engineering,University of Rochester, 3Department of Biomedical Genetics,University of Rochester Medical Center, 4Genomics Research Center,University of Rochester Medical Center, 5Division of Endocrinology and Metabolism, Department of Medicine,University of Rochester Medical Center
Autor
Institution
1Wilmot Cancer Institute,University of Rochester Medical Center, 2Department of Biomedical Engineering,University of Rochester, 3Department of Biomedical Genetics,University of Rochester Medical Center, 4Genomics Research Center,University of Rochester Medical Center, 5Division of Endocrinology and Metabolism, Department of Medicine,University of Rochester Medical Center
AUTHORS
1Wilmot Cancer Institute,University of Rochester Medical Center, 2Department of Biomedical Engineering,University of Rochester, 3Department of Biomedical Genetics,University of Rochester Medical Center, 4Genomics Research Center,University of Rochester Medical Center, 5Division of Endocrinology and Metabolism, Department of Medicine,University of Rochester Medical Center
Autor
Institution
1Wilmot Cancer Institute,University of Rochester Medical Center, 2Department of Biomedical Engineering,University of Rochester, 3Department of Biomedical Genetics,University of Rochester Medical Center, 4Genomics Research Center,University of Rochester Medical Center, 5Division of Endocrinology and Metabolism, Department of Medicine,University of Rochester Medical Center
AUTHORS